Kratom and opioid use disorder in the perioperative period: A case report on the expanding role of buprenorphine
Journal of Opioid Management · 2023
DOI: 10.5055/jom.2023.0762 ↗Kurz gefasst
Fallbericht in der Zeitschrift Journal of Opioid Management, 2023. Verfasst von Josiah Perez. Beteiligte Einrichtung: Department of Anesthesiology and Pain Medicine, Virginia Mason Medical Center, Seattle, Washington. ORCID: https://orcid.org/0000-0002-3889-9870. Hauptthemen laut MEDLINE: Buprenorphine, Mitragyna, Chronic Pain, Opioid-Related Disorders. Die Arbeit wurde bisher 4-mal zitiert (Crossref).
Themen: Sucht und Abhängigkeit
Abstract (Originalsprache)
Kratom (Mitragyna speciosa), an herbal plant gaining popularity as a treatment for chronic pain and opioid withdrawal symptoms, continues to be marketed and sold in the United States in an unregulated fashion. We present a patient with a history of opioid use disorder and taking kratom for chronic pain, who presented for an elective total knee replacement. We experienced challenges as well as successes with using buprenorphine as the primary medication to treat his post-operative pain, adding to the growing body of evidence to consider the use of buprenorphine both for kratom withdrawal and in the perioperative period.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Anesthesiology and Pain Medicine, Virginia Mason Medical Center, Seattle, Washington. ORCID: https://orcid.org/0000-0002-3889-9870.
Zitieren
APA
Perez, J. (2023). Kratom and opioid use disorder in the perioperative period: A case report on the expanding role of buprenorphine. Journal of Opioid Management. https://doi.org/10.5055/jom.2023.0762
Vancouver
Perez J. Kratom and opioid use disorder in the perioperative period: A case report on the expanding role of buprenorphine. Journal of Opioid Management. 2023. doi:10.5055/jom.2023.0762
BibTeX
@article{Perez2023,
author = {Perez, Josiah},
title = {Kratom and opioid use disorder in the perioperative period: A case report on the expanding role of buprenorphine},
journal = {Journal of Opioid Management},
year = {2023},
doi = {10.5055/jom.2023.0762}
}
EUVIMED